GLP-1RAs affect different types of liver disease
Study medication quality and tolerability Independent analysis of three separate samples compounded to contain 200 mg/ml demonstrated the product potency to be 190 mg/ml (95%) upon receipt, and potency reduced to 144 mg/ml (72%) at 4 weeks in one sample, and 161 mg/ml (80.5%) at 6 weeks in a separate batch
Ethics declarations Ethics approval statement and consent to participate All mouse procedures were approved by the Health Sciences Animal Ethics Committee of The University of Queensland (2021AE000537 and 2021AE000155) and by the US Department of Defense Animal Care and Use Review Office (approval SC00080.e001), and performed in accordance with the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes
And I started thinking that there was a pattern there that needed to be investigated. You found a 1.5% increase in hypotension in patients six months after starting GLP-1s
In 2026, once-daily pill versions of Wegovy are expected to be available, and Ozempic tablets are expected soon
2 What is peptide therapy